The Department of Veterans Affairs is launching a clinical trial of the prostate cancer drug Degarelix as a potential COVID-19 therapeutic:

“Scientists are testing degarelix because lab evidence suggests male hormones trigger the production of a protein called TMPRSS2 on lung tissue. The virus that causes -19 relies on TMPRSS2 to enter lung tissues”:

So, gentlemen, who’s ready to sign up to temporarily lower your male hormones?

And what’s the point of spending money on this therapeutic if it can’t even be used in half the population?


Recommended Twitchy Video